These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 28594853)
21. Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia - A GENFI study. Fenoglio C; Serpente M; Arcaro M; Carandini T; Sacchi L; Pintus M; Rotondo E; Borracci V; Ghezzi L; Bouzigues A; Russell LL; Foster PH; Ferry-Bolder E; van Swieten JC; Jiskoot LC; Seelaar H; Sánchez Valle R; Laforce R; Graff C; Vandenberghe R; de Mendonça A; Tiraboschi P; Santana I; Gerhard A; Levin J; Sorbi S; Otto M; Pasquier F; Ducharme S; Butler CR; Ber IL; Finger E; Carmela Tartaglia M; Masellis M; Rowe JB; Synofzik M; Moreno F; Borroni B; Rohrer JD; Arighi A; Galimberti D; Brain Behav Immun; 2024 Nov; 122():231-240. PubMed ID: 39153518 [TBL] [Abstract][Full Text] [Related]
22. White matter hyperintensities are seen only in Sudre CH; Bocchetta M; Cash D; Thomas DL; Woollacott I; Dick KM; van Swieten J; Borroni B; Galimberti D; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni G; Laforce R; Finger E; de Mendonça A; Sorbi S; Ourselin S; Cardoso MJ; Rohrer JD; Neuroimage Clin; 2017; 15():171-180. PubMed ID: 28529873 [TBL] [Abstract][Full Text] [Related]
23. Identification and functional characterization of novel variants of MAPT and GRN in Chinese patients with frontotemporal dementia. Cheng HR; Lin RR; Li HL; Xue YY; Gao PR; Chen DF; Tao QQ; Wu ZY Neurobiol Aging; 2023 Mar; 123():233-243. PubMed ID: 36641371 [TBL] [Abstract][Full Text] [Related]
24. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Moore KM; Nicholas J; Grossman M; McMillan CT; Irwin DJ; Massimo L; Van Deerlin VM; Warren JD; Fox NC; Rossor MN; Mead S; Bocchetta M; Boeve BF; Knopman DS; Graff-Radford NR; Forsberg LK; Rademakers R; Wszolek ZK; van Swieten JC; Jiskoot LC; Meeter LH; Dopper EG; Papma JM; Snowden JS; Saxon J; Jones M; Pickering-Brown S; Le Ber I; Camuzat A; Brice A; Caroppo P; Ghidoni R; Pievani M; Benussi L; Binetti G; Dickerson BC; Lucente D; Krivensky S; Graff C; Öijerstedt L; Fallström M; Thonberg H; Ghoshal N; Morris JC; Borroni B; Benussi A; Padovani A; Galimberti D; Scarpini E; Fumagalli GG; Mackenzie IR; Hsiung GR; Sengdy P; Boxer AL; Rosen H; Taylor JB; Synofzik M; Wilke C; Sulzer P; Hodges JR; Halliday G; Kwok J; Sanchez-Valle R; Lladó A; Borrego-Ecija S; Santana I; Almeida MR; Tábuas-Pereira M; Moreno F; Barandiaran M; Indakoetxea B; Levin J; Danek A; Rowe JB; Cope TE; Otto M; Anderl-Straub S; de Mendonça A; Maruta C; Masellis M; Black SE; Couratier P; Lautrette G; Huey ED; Sorbi S; Nacmias B; Laforce R; Tremblay ML; Vandenberghe R; Damme PV; Rogalski EJ; Weintraub S; Gerhard A; Onyike CU; Ducharme S; Papageorgiou SG; Ng ASL; Brodtmann A; Finger E; Guerreiro R; Bras J; Rohrer JD; Lancet Neurol; 2020 Feb; 19(2):145-156. PubMed ID: 31810826 [TBL] [Abstract][Full Text] [Related]
25. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America. Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100 [TBL] [Abstract][Full Text] [Related]
26. A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases. Bit-Ivan EN; Suh E; Shim HS; Weintraub S; Hyman BT; Arnold SE; McCarty-Wood E; Van Deerlin VM; Schneider JA; Trojanowski JQ; Frosch MP; Baker MC; Rademakers R; Mesulam M; Bigio EH J Neuropathol Exp Neurol; 2014 May; 73(5):467-73. PubMed ID: 24709683 [TBL] [Abstract][Full Text] [Related]
27. Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations. Boeve BF; Rosen H Adv Exp Med Biol; 2021; 1281():77-92. PubMed ID: 33433870 [TBL] [Abstract][Full Text] [Related]
28. Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation. Bruni AC; Momeni P; Bernardi L; Tomaino C; Frangipane F; Elder J; Kawarai T; Sato C; Pradella S; Wakutani Y; Anfossi M; Gallo M; Geracitano S; Costanzo A; Smirne N; Curcio SA; Mirabelli M; Puccio G; Colao R; Maletta RG; Kertesz A; St George-Hyslop P; Hardy J; Rogaeva E Neurology; 2007 Jul; 69(2):140-7. PubMed ID: 17620546 [TBL] [Abstract][Full Text] [Related]
29. Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients. Guven G; Lohmann E; Bras J; Gibbs JR; Gurvit H; Bilgic B; Hanagasi H; Rizzu P; Heutink P; Emre M; Erginel-Unaltuna N; Just W; Hardy J; Singleton A; Guerreiro R PLoS One; 2016; 11(9):e0162592. PubMed ID: 27632209 [TBL] [Abstract][Full Text] [Related]
30. A Novel Loss-of-Function GRN Mutation p.(Tyr229*): Clinical and Neuropathological Features. Kuuluvainen L; Pöyhönen M; Pasanen P; Siitonen M; Rummukainen J; Tienari PJ; Paetau A; Myllykangas L J Alzheimers Dis; 2017; 55(3):1167-1174. PubMed ID: 27767988 [TBL] [Abstract][Full Text] [Related]
31. The heritability and genetics of frontotemporal lobar degeneration. Rohrer JD; Guerreiro R; Vandrovcova J; Uphill J; Reiman D; Beck J; Isaacs AM; Authier A; Ferrari R; Fox NC; Mackenzie IR; Warren JD; de Silva R; Holton J; Revesz T; Hardy J; Mead S; Rossor MN Neurology; 2009 Nov; 73(18):1451-6. PubMed ID: 19884572 [TBL] [Abstract][Full Text] [Related]
32. A mutation in the 5'-UTR of GRN gene associated with frontotemporal lobar degeneration: phenotypic variability and possible pathogenetic mechanisms. Puoti G; Lerza MC; Ferretti MG; Bugiani O; Tagliavini F; Rossi G J Alzheimers Dis; 2014; 42(3):939-47. PubMed ID: 25024321 [TBL] [Abstract][Full Text] [Related]
33. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Yu CE; Bird TD; Bekris LM; Montine TJ; Leverenz JB; Steinbart E; Galloway NM; Feldman H; Woltjer R; Miller CA; Wood EM; Grossman M; McCluskey L; Clark CM; Neumann M; Danek A; Galasko DR; Arnold SE; Chen-Plotkin A; Karydas A; Miller BL; Trojanowski JQ; Lee VM; Schellenberg GD; Van Deerlin VM Arch Neurol; 2010 Feb; 67(2):161-70. PubMed ID: 20142524 [TBL] [Abstract][Full Text] [Related]
34. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. Van Langenhove T; van der Zee J; Gijselinck I; Engelborghs S; Vandenberghe R; Vandenbulcke M; De Bleecker J; Sieben A; Versijpt J; Ivanoiu A; Deryck O; Willems C; Dillen L; Philtjens S; Maes G; Bäumer V; Van Den Broeck M; Mattheijssens M; Peeters K; Martin JJ; Michotte A; Santens P; De Jonghe P; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C JAMA Neurol; 2013 Mar; 70(3):365-73. PubMed ID: 23338682 [TBL] [Abstract][Full Text] [Related]
35. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum. Gossye H; Van Mossevelde S; Sieben A; Bjerke M; Hendrickx Van de Craen E; van der Zee J; De Deyn PP; De Bleecker J; Versijpt J; van den Ende J; Deryck O; Bourgeois P; Bier JC; Goethals M; Vandenberghe R; Engelborghs S; Van Broeckhoven C Brain; 2023 Apr; 146(4):1624-1636. PubMed ID: 36171642 [TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia. Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429 [TBL] [Abstract][Full Text] [Related]
37. Longitudinal multimodal MRI as prognostic and diagnostic biomarker in presymptomatic familial frontotemporal dementia. Jiskoot LC; Panman JL; Meeter LH; Dopper EGP; Donker Kaat L; Franzen S; van der Ende EL; van Minkelen R; Rombouts SARB; Papma JM; van Swieten JC Brain; 2019 Jan; 142(1):193-208. PubMed ID: 30508042 [TBL] [Abstract][Full Text] [Related]
38. MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium. Pastor P; Moreno F; Clarimón J; Ruiz A; Combarros O; Calero M; López de Munain A; Bullido MJ; de Pancorbo MM; Carro E; Antonell A; Coto E; Ortega-Cubero S; Hernandez I; Tárraga L; Boada M; Lleó A; Dols-Icardo O; Kulisevsky J; Vázquez-Higuera JL; Infante J; Rábano A; Fernández-Blázquez MÁ; Valentí M; Indakoetxea B; Barandiarán M; Gorostidi A; Frank-García A; Sastre I; Lorenzo E; Pastor MA; Elcoroaristizabal X; Lennarz M; Maier W; Rámirez A; Serrano-Ríos M; Lee SE; Sánchez-Juan P; J Alzheimers Dis; 2016; 49(2):343-52. PubMed ID: 26444794 [TBL] [Abstract][Full Text] [Related]
39. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Le Ber I; Camuzat A; Hannequin D; Pasquier F; Guedj E; Rovelet-Lecrux A; Hahn-Barma V; van der Zee J; Clot F; Bakchine S; Puel M; Ghanim M; Lacomblez L; Mikol J; Deramecourt V; Lejeune P; de la Sayette V; Belliard S; Vercelletto M; Meyrignac C; Van Broeckhoven C; Lambert JC; Verpillat P; Campion D; Habert MO; Dubois B; Brice A; Brain; 2008 Mar; 131(Pt 3):732-46. PubMed ID: 18245784 [TBL] [Abstract][Full Text] [Related]
40. Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Van Mossevelde S; van der Zee J; Gijselinck I; Engelborghs S; Sieben A; Van Langenhove T; De Bleecker J; Baets J; Vandenbulcke M; Van Laere K; Ceyssens S; Van den Broeck M; Peeters K; Mattheijssens M; Cras P; Vandenberghe R; De Jonghe P; Martin JJ; De Deyn PP; Cruts M; Van Broeckhoven C; Brain; 2016 Feb; 139(Pt 2):452-67. PubMed ID: 26674655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]